ホーム > 田尻 和子/ Tajiri, Kazuko

田尻 和子

ALUMNI 2025年11月現在、筑波大学が主たる所属機関ではありません

Tajiri, Kazuko

国立研究開発法人国立がん研究センター東病院 , 循環器科 , 科長
National Cancer Center Hospital East , Department of Cardiology, , Chief

http://www.md.tsukuba.ac.jp/clinical-med/cardiology/

関連記事はまだありません。

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. CD300a immunoreceptor regulates ischemic tissue damage and adverse remodeling in the mouse heart and kidney. Nanako Nishiyama; Hitoshi Koizumi; Chigusa Nakahashi-Oda; Satoshi Fujiyama (+11 著者) Akira Shibuya
      The Journal of clinical investigation (2025)
  2. 2. Incidence and Risk of Hypertension and Proteinuria in Cancer Patients Treated with Lenvatinib: A Systematic Review and Meta-analysis. Yuma Shibutani; Atsuko Suzuki; Takuro Imaoka; Kazuko Tajiri
      The oncologist (2025)
  3. 3. Multi-scale Feature Learning with CNN-RNN-Attention Framework for ECG-based Cancer Therapy-Related Cardiac Dysfunction Detection Natsu Suyama; Akira Furui; Takio Kurita; Kazuko Tajiri
      Proceedings of the 47th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2025) (2025)
  4. 4. Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels. Yuma Shibutani; Atsushi Kawanobe; Shinya Suzuki; Takuro ImaokaKazuko Tajiri
      Journal of immunotherapy (Hagerstown, Md. : 1997) 48: 183 (2025)
  5. 5. A Fatal Case of Immune Checkpoint Inhibitor-Associated Myocarditis with Severe Right Ventricular Failure. Takuro Imaoka; Kimi Sato; Shingo Sakashita; Yuma Shibutani (+3 著者) Kazuko Tajiri
      International heart journal 66: 511 (2025)
  6. 6. Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels. Yuma Shibutani; Atsushi Kawanobe; Shinya Suzuki; Takuro ImaokaKazuko Tajiri
      Journal of immunotherapy (Hagerstown, Md. : 1997) (2025)
  7. 7. Withdrawal of Cardioprotective Therapy in Patients With Recovered Cancer Therapy-Related Cardiac Dysfunction. Yuma Shibutani; Takuro Imaoka; Atsuko Suzuki; Kazuko Tajiri
      JACC. CardioOncology 7: 189 (2025)
  8. 8. Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism in the direct oral anticoagulants era: Findings from the TULIPE registry. Yuki Ishizuka; Kazuko Tajiri; Hiroyuki Naito; Momoko Murata (+2 著者) Tomoko Ishizu
      PloS one 20: e0329025 (2025)
  9. 9. 4E-BP3 deficiency impairs dendritic cell activation and CD4+ T cell differentiation and attenuates α-myosin-specific T cell-mediated myocarditis in mice. Siqi Li; Kazuko Tajiri; Zixun Yuan; Yoshiko Murakata (+3 著者) Nobuyuki Murakoshi
      Basic research in cardiology 120: 225 (2024) Semantic Scholar
  10. 10. Addressing Cardiotoxicity Risks in Long-term Use of Human Epidermal Growth Factor Receptor 2 Inhibitors. Kazuko Tajiri
      Internal medicine (Tokyo, Japan) 64: 1784 (2024) Semantic Scholar
  11. 11. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation. Haruka Mori; Dongzhu Xu; Yuzuno Shimoda; Zixun Yuan (+7 著者) Nobuyuki Murakoshi
      Scientific reports 14: 15422 (2024) Semantic Scholar
  12. 12. Impact of cancer in patients with aortic stenosis undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis. Takumi Osawa; Kazuko Tajiri; Tomoya Hoshi; Masaki IedaTomoko Ishizu
      International journal of cardiology. Heart & vasculature 52: 101410 (2024) Semantic Scholar
  13. 13. An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice. Yuta Okabe; Nobuyuki Murakoshi; Nagomi Kurebayashi; Hana Inoue (+16 著者) Masashi Yanagisawa
      Proceedings of the National Academy of Sciences of the United States of America 121: e2218204121 (2024) Semantic Scholar
  14. 14. Immune Checkpoint Inhibitor Myotoxicities: An Autoimmune Perspective. Kazuko Tajiri
      Internal medicine (Tokyo, Japan) 63: 3129 (2024) Semantic Scholar
  15. 15. Early Detection and Prediction of Anthracycline-Induced Cardiotoxicity - A Prospective Cohort Study. Keiko Inoue; Tomoko Machino-Ohtsuka; Yoko Nakazawa; Noriko Iida (+8 著者) Kazuko Tajiri
      Circulation journal : official journal of the Japanese Circulation Society 88: 751 (2024) Semantic Scholar
  16. 16. Successful Treatment of Malignant Lymphoma Following Transcatheter Aortic Valve Replacement: A Case Report. Takumi Osawa; Kazuko Tajiri; Tomoya Hoshi; Masaki IedaTomoko Ishizu
      Internal medicine (Tokyo, Japan) 63: 2433 (2024) Semantic Scholar
  17. 17. A Predictive Model for Cancer-Associated Thrombosis in Japanese Cancer Patients: Findings from the J-Khorana Registry. Masaaki Shoji; Yugo Yamashita; Masanobu Ishii; Hitoki Inoue (+12 著者) Kenichi Tsujita
      TH open : companion journal to thrombosis and haemostasis 8: e9-e18 (2024) Semantic Scholar
  18. 18. Autoantibody profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study. Siqi Li; DongZhu Xu; Nobuyuki Murakoshi; Zixun Yuan (+1 著者) Kazuko Tajiri
      Frontiers in immunology 15: 1423622 (2024) Semantic Scholar
  19. 19. Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (Nature Medicine, (2023), 29, 12, (3100-3110), 10.1038/s41591-023-02591-2) Charlotte Fenioux; Baptiste Abbar; Samia Boussouar; Marie Bretagne (+95 著者) Michelle Rosenzwajg
      Nature Medicine 30: 910 (2024)
  20. 20. Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (Nature Medicine, (2023), 29, 12, (3100-3110), 10.1038/s41591-023-02591-2) Charlotte Fenioux; Baptiste Abbar; Samia Boussouar; Marie Bretagne (+95 著者) Michelle Rosenzwajg
      Nature Medicine 29: 3268 (2023)
1 2 3 … 8
  1. 1. 最新主要文献とガイドラインでみる 循環器内科学レビュー2025-’26 (レビューシリーズ) 田尻和子 (担当:分担執筆, 範囲:(V章)心筋症・心筋炎・心膜疾患 抗がん薬による心筋症・心筋炎)
    総合医学社 2025年1月27日 (ISBN: 4883784797)
  2. 2. 今日の治療指針 2025年版[デスク判] 田尻和子 (担当:分担執筆, 範囲:心筋炎)
    医学書院 2025年1月10日 (ISBN: 4260057170)
  3. 3. 腫瘍循環器診療 実践トレーニング 田尻和子
    メジカルビュー社 2024年3月14日 (ISBN: 4758322147)
  4. 4. 今日の治療指針 : 私はこう治療している 田尻和子 (担当:分担執筆, 範囲:がんに伴う循環器疾患)
    医学書院 2024年1月 (ISBN: 9784260053426)
  5. 5. 2023年改訂版心筋炎の診断・治療に関するガイドライン 田尻和子 (担当:共著, 範囲:膠原病性心筋炎、薬剤性心筋炎、CQ1 急性心筋炎の患者に対する心筋生検の 施行は推奨されるか？)
    日本循環器学会 2023年3月
  6. 6. がん免疫療法ガイドライン 第3版 田尻和子; 他; 日本臨床腫瘍学会 (担当:共著, 範囲:心筋炎を含む心血管障害)
    金原出版 2023年3月 (ISBN: 9784307102124)
  7. 7. 腫瘍循環器診療ハンドブック 田尻和子 (担当:分担執筆, 範囲:心筋炎)
    メジカルビュー社 2020年11月 (ISBN: 9784758319669)
  8. 8. Gene delivery of Socs1 inhibits inflammatory and pathogenic responses in autoimmune myocarditis in mice 田尻, 和子
    2012年3月
  9. 9. 循環器研修ノート 下條信威; 田尻和子; 廣江道昭 (担当:分担執筆, 範囲:多臓器不全（MOF,MODS）)
    診断と治療社 2010年3月

 3,711 total views